Evidence map›Paper›PMID 33562083›Full record

ArticleCells2021

A Novel, LAT/Lck Double Deficient T Cell Subline J.CaM1.7 for Combined Analysis of Early TCR Signaling.

Inmaculada Vico-Barranco, Mikel M Arbulo-Echevarria, Isabel Serrano-García, Alba Pérez-Linaza, José M Miranda-Sayago, Arkadiusz Miazek, Isaac Narbona-Sánchez, Enrique Aguado

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Integrated bioinformatics andFrontiers in nutrition · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Inmaculada Vico-BarrancoInstitute of Biomedical Research Cadiz (INIBICA), 11009 Cádiz, Spain.ORCID 0000-0002-4279-7244
Mikel M Arbulo-EchevarriaInstitute of Biomedical Research Cadiz (INIBICA), 11009 Cádiz, Spain.
Isabel Serrano-GarcíaRheumatology Section, Unit of Orthopedic Surgery, Traumatology and Rheumatology, HUPM, 11009 Cádiz, Spain.ORCID 0000-0002-7793-8334
Alba Pérez-LinazaRheumatology Section, Unit of Orthopedic Surgery, Traumatology and Rheumatology, HUPM, 11009 Cádiz, Spain.
José M Miranda-SayagoInstitute of Biomedical Research Cadiz (INIBICA), 11009 Cádiz, Spain.ORCID 0000-0001-7385-6051
Arkadiusz MiazekDepartment of Biochemistry and Molecular Biology, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.ORCID 0000-0002-7210-2706
Isaac Narbona-SánchezInstitute of Biomedical Research Cadiz (INIBICA), 11009 Cádiz, Spain.ORCID 0000-0003-1696-267X
Enrique AguadoInstitute of Biomedical Research Cadiz (INIBICA), 11009 Cádiz, Spain.
Biomedical Research and Innovation Institute of Cadiz · ESUniversidad de Cádiz · ESWrocław University of Environmental and Life Sciences · PL

Funding

Consejería de Salud y Familias, Junta de Andalucía PI-0055-2017Fundación para la Gestión de la Investigación Biomédica de Cádiz I14N- 599 CO15
6 · The paper itself

Abstract

Intracellular signaling through the T cell receptor (TCR) is essential for T cell development and function. Proper TCR signaling requires the sequential activities of Lck and ZAP-70 kinases, which result in the phosphorylation of tyrosine residues located in the CD3 ITAMs and the LAT adaptor, respectively. LAT, linker for the activation of T cells, is a transmembrane adaptor protein that acts as a scaffold coupling the early signals coming from the TCR with downstream signaling pathways leading to cellular responses. The leukemic T cell line Jurkat and its derivative mutants J.CaM1.6 (Lck deficient) and J.CaM2 (LAT deficient) have been widely used to study the first signaling events upon TCR triggering. In this work, we describe the loss of LAT adaptor expression found in a subline of J.CaM1.6 cells and analyze cis-elements responsible for the LAT expression defect. This new cell subline, which we have called J.CaM1.7, can re-express LAT adaptor after Protein Kinase C (PKC) activation, which suggests that activation-induced LAT expression is not affected in this new cell subline. Contrary to J.CaM1.6 cells, re-expression of Lck in J.CaM1.7 cells was not sufficient to recover TCR-associated signals, and both LAT and Lck had to be introduced to recover activatory intracellular signals triggered after CD3 crosslinking. Overall, our work shows that the new LAT negative J.CaM1.7 cell subline could represent a new model to study the functions of the tyrosine kinase Lck and the LAT adaptor in TCR signaling, and their mutual interaction, which seems to constitute an essential early signaling event associated with the TCR/CD3 complex.

Indexed as

Signal TransductionAdaptor Proteins, Signal TransducingBase SequenceCalciumCell SurvivalEnzyme ActivationHumansJurkat CellsLentivirusLymphocyte Specific Protein Tyrosine Kinase p56(lck)Membrane ProteinsPlasmidsPromoter Regions, GeneticProtein Kinase CReceptors, Antigen, T-CellAdaptor Proteins, Signal TransducingCalciumLAT protein, humanLymphocyte Specific Protein Tyrosine Kinase p56(lck)Membrane ProteinsProtein Kinase CReceptors, Antigen, T-CellJ.CaM1.6LATLcksignalingTCR

Identifiers

PMID33562083
PMCPMC7915312
OpenAlexW3126537168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.